Brett B. Busch

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...
- Patent number 11,866,450
- Issue date Jan 9, 2024
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulator of cystic fibrosis transmembrane conductance regulator, p...
- Patent number 11,186,566
- Issue date Nov 30, 2021
- Vertex Pharmaceuticals Incorporated
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator,...
- Patent number 11,066,417
- Issue date Jul 20, 2021
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulator of cystic fibrosis transmembrane conductance regulator, p...
- Patent number 10,570,115
- Issue date Feb 25, 2020
- Vertex Pharmaceuticals Incorporated
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LXR modulators
- Patent number 9,751,869
- Issue date Sep 5, 2017
- Bristol-Myers Squibb Company
- Ellen K. Kick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole based LXR modulators
- Patent number 9,000,022
- Issue date Apr 7, 2015
- Exelixis Patent Company LLC
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of LXR
- Patent number 8,703,805
- Issue date Apr 22, 2014
- Exelixis Patent Company LLC
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LXR modulators
- Patent number 8,618,154
- Issue date Dec 31, 2013
- Bristol-Myers Squibb Company
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole based LXR modulators
- Patent number 8,569,352
- Issue date Oct 29, 2013
- Exelixis Patent Company LLC
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azepinoindole derivatives as pharmaceutical agents
- Patent number 8,524,704
- Issue date Sep 3, 2013
- Exelixis, Inc.
- Brett Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LXR and FXR modulators
- Patent number 7,998,995
- Issue date Aug 16, 2011
- Exelixis Patent Company LLC
- Brant Clayton Boren
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
- Patent number 7,977,489
- Issue date Jul 12, 2011
- Exelixis, Inc.
- Richard Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azepinoindole derivatives as pharmaceutical agents
- Patent number 7,595,311
- Issue date Sep 29, 2009
- Exelixis, Inc.
- Brett Busch
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20240368189
- Publication date Nov 7, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES
- Publication number 20240335544
- Publication date Oct 10, 2024
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bifunctional Folate Receptor Binding Compounds
- Publication number 20240165250
- Publication date May 23, 2024
- Lycia Therapeutics, Inc.
- Jason G. Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES
- Publication number 20230250091
- Publication date Aug 10, 2023
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREX1 INHIBITORS AND USES THEREOF
- Publication number 20230234943
- Publication date Jul 27, 2023
- Tempest Therapeutics, Inc.
- Thomas Walter DUBENSKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell Surface Receptor Binding Compounds and Conjugates
- Publication number 20230158155
- Publication date May 25, 2023
- Lycia Therapeutics, Inc.
- Brett Bradley BUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20220313698
- Publication date Oct 6, 2022
- Vertex Pharmaceuticals Incorporated
- Alexander Russell Abela
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...
- Publication number 20220306606
- Publication date Sep 29, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20220106331
- Publication date Apr 7, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...
- Publication number 20200283405
- Publication date Sep 10, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20190248809
- Publication date Aug 15, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulator of Cystic Fibrosis Transmembrane Conductance Regulator, P...
- Publication number 20180093969
- Publication date Apr 5, 2018
- Vertex Pharmaceuticals Incorporated
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LXR MODULATORS
- Publication number 20160289222
- Publication date Oct 6, 2016
- Bristol-Myers Squibb Company
- Ellen K. Kick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LXR MODULATORS
- Publication number 20160280661
- Publication date Sep 29, 2016
- Exelixis Patent Company LLC
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LXR MODULATORS
- Publication number 20150299136
- Publication date Oct 22, 2015
- Bristol-Myers Squibb Company
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LXR MODULATORS
- Publication number 20140163081
- Publication date Jun 12, 2014
- Exelixis Patent Company LLC
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLE BASED LXR MODULATORS
- Publication number 20140038964
- Publication date Feb 6, 2014
- Exelixis Patent Company LLC
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LXR MODULATORS
- Publication number 20120071534
- Publication date Mar 22, 2012
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF LXR
- Publication number 20100331295
- Publication date Dec 30, 2010
- Exelixis, Inc.
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azepinoindole Derivatives As Pharmaceutical Agents
- Publication number 20100173824
- Publication date Jul 8, 2010
- Exelixis, Inc.
- Brett Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLE BASED LXR MODULATORS
- Publication number 20100075964
- Publication date Mar 25, 2010
- Exelixis, Inc.
- Brett B. Busch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LXR and FXR Modulators
- Publication number 20100069367
- Publication date Mar 18, 2010
- Exelixis, Inc.
- Brant Clayton Boren
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azepinoindole Derivatives As Pharmaceutical Agents
- Publication number 20090203577
- Publication date Aug 13, 2009
- Exelixis, Inc.
- Tae-Gon Baik
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical Compositions
- Publication number 20090197870
- Publication date Aug 6, 2009
- Exelixis, Inc.
- Richard Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azepinoindole derivatives as pharmaceutical agents
- Publication number 20050054634
- Publication date Mar 10, 2005
- Brett Busch
- C07 - ORGANIC CHEMISTRY

Brett B. Busch

Person

Patents Grantslast 30 patents

Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...

Modulator of cystic fibrosis transmembrane conductance regulator, p...

Modulators of cystic fibrosis transmembrane conductance regulator,...

Modulator of cystic fibrosis transmembrane conductance regulator, p...

LXR modulators

Imidazole based LXR modulators

Modulators of LXR

LXR modulators

Imidazole based LXR modulators

Azepinoindole derivatives as pharmaceutical agents

LXR and FXR modulators

Benzylthiazolone inhibitors of estrogen-related receptors (ERR)

Azepinoindole derivatives as pharmaceutical agents

Patents Applicationslast 30 patents

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

Bifunctional Folate Receptor Binding Compounds

ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

TREX1 INHIBITORS AND USES THEREOF

Cell Surface Receptor Binding Compounds and Conjugates

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

Modulator of Cystic Fibrosis Transmembrane Conductance Regulator, P...

LXR MODULATORS

LXR MODULATORS

LXR MODULATORS

LXR MODULATORS

IMIDAZOLE BASED LXR MODULATORS

LXR MODULATORS

MODULATORS OF LXR

Azepinoindole Derivatives As Pharmaceutical Agents

IMIDAZOLE BASED LXR MODULATORS

LXR and FXR Modulators

Azepinoindole Derivatives As Pharmaceutical Agents

Pharmaceutical Compositions

Azepinoindole derivatives as pharmaceutical agents